QUINTESSENTIAL: A multicenter phase 2 study evaluating the efficacy and safety of BMS-986393 in patients with quadruple-class exposed relapsed or refractory multiple myeloma Meeting Abstract
| Authors: | Patel, K.; Nadeem, O.; Munshi, N.; Iida, S.; Mailankody, S.; Neri, P.; Gregory, T.; Piasecki, J.; Ziyad, S.; Hu, H.; Groeneveld, S.; Johnston, S.; Pulham, T.; Wong, S.; Davis, J.; Larson, S.; Bal, S. |
| Abstract Title: | QUINTESSENTIAL: A multicenter phase 2 study evaluating the efficacy and safety of BMS-986393 in patients with quadruple-class exposed relapsed or refractory multiple myeloma |
| Meeting Title: | 21st Annual Meeting and Exposition of the International Myeloma Society |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 24 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2024 Sep 25-28 |
| Meeting Location: | Rio de Janeiro, Brazil |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2024-09-01 |
| Start Page: | S77 |
| Language: | English |
| ACCESSION: | WOS:001325737900125 |
| PROVIDER: | wos |
| DOI: | 10.1016/S2152-2650(24)01965-7 |
| Notes: | Meeting Abstract: P-062 -- Source: Wos |
